Anti-SARS-CoV-2 inactivated vaccine in patients with ANCA-associated vasculitis: Immunogenicity, safety, antibody decay and the booster dose. (2022). Clinics, 78, 100150. https://doi.org/10.1016/j.clinsp.2022.100150